PNC Financial Services Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.5K Buy
6,317
+846
+15% +$11.4K ﹤0.01% 2897
2025
Q4
$61.4K Sell
5,471
-1,477
-21% -$16.9K ﹤0.01% 3088
2025
Q3
$80.3K Sell
6,948
-554
-7% -$6.49K ﹤0.01% 2942
2025
Q2
$91.8K Buy
7,502
+40
+0.5% +$503 ﹤0.01% 2762
2025
Q1
$107K Sell
7,462
-302
-4% -$4.71K ﹤0.01% 2619
2024
Q4
$124K Buy
7,764
+97
+1% +$1.92K ﹤0.01% 2547
2024
Q3
$184K Sell
7,667
-464
-6% -$10.6K ﹤0.01% 2249
2024
Q2
$162K Sell
8,131
-6,753
-45% -$132K ﹤0.01% 2293
2024
Q1
$296K Sell
14,884
-5,274
-26% -$102K ﹤0.01% 1895
2023
Q4
$452K Sell
20,158
-800
-4% -$16.5K ﹤0.01% 1581
2023
Q3
$424K Sell
20,958
-2,592
-11% -$58.8K ﹤0.01% 1595
2023
Q2
$602K Buy
23,550
+2,305
+11% +$60.7K ﹤0.01% 1435
2023
Q1
$632K Buy
21,245
+1,481
+7% +$43K ﹤0.01% 1396
2022
Q4
$535K Sell
19,764
-766
-4% -$18.7K ﹤0.01% 1485
2022
Q3
$447K Sell
20,530
-249
-1% -$6.51K ﹤0.01% 1580
2022
Q2
$570K Buy
20,779
+1,828
+10% +$52.5K ﹤0.01% 1461
2022
Q1
$636K Sell
18,951
-7,268
-28% -$234K ﹤0.01% 1491
2021
Q4
$909K Buy
26,219
+8,108
+45% +$262K ﹤0.01% 1343
2021
Q3
$567K Buy
18,111
+10,074
+125% +$342K ﹤0.01% 1533
2021
Q2
$291K Sell
8,037
-831
-9% -$34.4K ﹤0.01% 1983
2021
Q1
$389K Sell
8,868
-1,117
-11% -$52.4K ﹤0.01% 1742
2020
Q4
$457K Sell
9,985
-3,332
-25% -$139K ﹤0.01% 1536
2020
Q3
$442K Sell
13,317
-887
-6% -$28.3K ﹤0.01% 1418
2020
Q2
$418K Sell
14,204
-629
-4% -$18.2K ﹤0.01% 1488
2020
Q1
$400K Sell
14,833
-548
-4% -$16.4K ﹤0.01% 1409
2019
Q4
$519K Sell
15,381
-2,252
-13% -$81.5K ﹤0.01% 1457
2019
Q3
$660K Sell
17,633
-1,722
-9% -$65.7K ﹤0.01% 1449
2019
Q2
$845K Sell
19,355
-2,319
-11% -$99.2K ﹤0.01% 1354
2019
Q1
$923K Sell
21,674
-848
-4% -$38K ﹤0.01% 1332
2018
Q4
$1.01M Sell
22,522
-1,177
-5% -$61.7K ﹤0.01% 1250
2018
Q3
$1.63M Buy
23,699
+23,490
+11,239% +$1.51M ﹤0.01% 1140
2018
Q2
$11K Sell
209
-26,130
-99% -$1.38M ﹤0.01% 3647
2018
Q1
$1.21M Sell
26,339
-4,209
-14% -$200K ﹤0.01% 1230
2017
Q4
$1.41M Buy
30,548
+437
+1% +$20.1K ﹤0.01% 1179
2017
Q3
$1.35M Sell
30,111
-1,621
-5% -$69.2K ﹤0.01% 1170
2017
Q2
$1.25M Sell
31,732
-2,260
-7% -$85.4K ﹤0.01% 1173
2017
Q1
$1.29M Sell
33,992
-2,947
-8% -$115K ﹤0.01% 1172
2016
Q4
$1.37M Sell
36,939
-1,889
-5% -$67.5K ﹤0.01% 1145
2016
Q3
$1.34M Sell
38,828
-3,519
-8% -$123K ﹤0.01% 1150
2016
Q2
$1.38M Sell
42,347
-5,315
-11% -$163K ﹤0.01% 1119
2016
Q1
$1.37M Sell
47,662
-9,017
-16% -$240K ﹤0.01% 1118
2015
Q4
$1.89M Sell
56,679
-14,198
-20% -$441K ﹤0.01% 928
2015
Q3
$2.02M Sell
70,877
-22,021
-24% -$768K ﹤0.01% 934
2015
Q2
$3.76M Sell
92,898
-23,758
-20% -$1.07M ﹤0.01% 746
2015
Q1
$5.74M Sell
116,656
-23,916
-17% -$1.11M 0.01% 647
2014
Q4
$6.39M Buy
+140,572
New +$5.52M 0.01% 612

Other funds holding AVNS

PNC Financial Services Group's AVNS Position: Q1 2026 in Review

PNC Financial Services Group increased its Avanos Medical (AVNS) stake by 15% in Q1 2026, buying an estimated $11.4K and bringing the position to 6,317 shares worth $88.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

PNC Financial Services Group first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.39M in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • PNC Financial Services Group held 6,317 shares of Avanos Medical worth $88.5K as of Q1 2026.
  • PNC Financial Services Group bought 846 Avanos Medical shares in Q1 2026, an estimated $11.4K.
  • Avanos Medical made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2897 holding.
  • PNC Financial Services Group first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • PNC Financial Services Group's Avanos Medical position peaked at $6.39M in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.